跳至主要内容
临床试验/ACTRN12612000054819
ACTRN12612000054819已完成2 期

A double-blind randomised controlled trial to evaluate the efficacy of 20,000 IU/wk cholecalciferol in reducing respiratory tract infection in a cohort of healthy young adults

Menzies Research Institute Tasmania, University of Tasmania0 个研究点目标入组 32 人开始时间: 2012年1月11日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
All

入选标准

  • Students undertaking study at the MS1 building of University of Tasmania Medical Sciences Precinct (17 Liverpool St Hobart TAS) for the full duration between May and September 2012

排除标准

  • -Persons who have used tobacco within the 6 months preceding study entry
  • -Persons who have used any vitamin D (cholecalciferol or ergocalciferol) supplements or calcium supplements within the 3 months preceding study entry and/or persons who refuse to not start taking any such supplement during the study
  • -Persons using any immunomodulatory medication, diuretic medication, antiepileptic medication, or barbiturates.
  • -Persons who presently have been diagnosed with any chronic infectious disease (e.g. HIV, tuberculosis), chronic immune deficiency or autoimmune condition, or respiratory condition (e.g. asthma, chronic obstructive pulmonary disease).
  • -Persons who are hypersensitive to vitamin D.

研究者

发起方
Menzies Research Institute Tasmania, University of Tasmania

相似试验

已完成
3 期
A double-blind randomised controlled study to evaluate the effectiveness of orally-dosedPalmitoylethanolamide (PEA) compared to placebo for reducing pain severity and duration of migraines in otherwise healthy participants aged 18 years and olderMigrainesNeurological - Other neurological disorders
ACTRN12620000598987RDC Global Pty Ltd80
已完成
3 期
A double-blind randomised controlled study to evaluate the effectiveness of orally-dosed Palmitoylethanolamide (PEA) compared to ibuprofen for reducing pain severityand duration of headaches in healthy participants aged 18 years and older.
ACTRN12618000294257RDC Global Pty Ltd94
已完成
3 期
A double-blind randomised controlled study to evaluate the effectiveness of a fermented red ginseng extract supplement (FermenGIN) compared to placebo on blood circulation parameters in an adult population.Peripheral blood circulationCardiovascular - Other cardiovascular diseasesAlternative and Complementary Medicine - Other alternative and complementary medicine
ACTRN12620001179921RDC Global Pty Ltd183
招募中
不适用
Double-blinded randomized controlled trial to evaluate the effect of dietary supplements, Propolis, Royal jelly and resveratrol for infertility treatment of aging wome
JPRN-UMIN000016992St. Marianna University School of Medicine384
已完成
不适用
Muscle Strength vs. Muscle Endurance Training for Osteoarthritis of the Knee in Older Adults; A double-blind, randomized sham exercise-controlled trial
ACTRN12605000230651niversity of Sydney75